- Tytuł:
- NY-ESO-1-specific T cell receptor-engineered T cells and Tranilast, a TRPV2 antagonist bivalent treatment enhances the killing of esophageal cancer: a dual-targeted cancer therapeutic route
- Autorzy:
- Temat:
-
Adoptive therapy
Cytotoxic T lymphocytes
Esophageal cancer (EC)
NY-ESO-1 antigen
T cell receptor-engineered T cell (TCR-T)
Tranilast
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Cytology
QH573-671 - Źródło:
- Cancer Cell International, Vol 24, Iss 1, Pp 1-18 (2024)
- Opis pliku:
- electronic resource
- Relacje:
- https://doaj.org/toc/1475-2867
- Dostęp URL:
- https://doaj.org/article/18ff037bbc2044b898ab952d16040a0f  Link otwiera się w nowym oknie
Czasopismo naukowe